Document is current
Any future updates will be listed below
-
Authors
Kunte, Sophie Carina https://orcid.org/0009-0003-3175-952X
Delker, Astrid
Holzgreve, Adrien
Zacherl, Mathias J.
Scheifele, Maximilian
Casuscelli, Jozefina
Gildehaus, Franz Josef
Unterrainer, Marcus
Ilhan, Harun
Werner, Rudolf A.
Unterrainer, Lena M.
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 13 March 2025
Accepted: 25 April 2025
First Online: 6 May 2025
Declarations
:
: This analysis was performed in compliance with the principles of the Declaration of Helsinki and was approved by the institutional ethics board of the LMU Munich (IRB 24–0982).
: Not applicable.
: MJZ: speaker honoraria from Novartis, SIRTEX and Terumo, advisory board for Boston Scientific. RAW: speaker honoraria from Novartis/AAA and PentixaPharm, advisory board work for Novartis/AAA and Bayer. AH reports compensation for scientific consulting by ABX advanced biochemical compounds outside the submitted work. L.M.U. reports fees from Novartis (speaker), Telix (consultant) and Astellas Pharma Inc. (speaker) outside of the submitted work.
